Yariv Mazor

1.8k total citations
24 papers, 1.3k citations indexed

About

Yariv Mazor is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Immunology. According to data from OpenAlex, Yariv Mazor has authored 24 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Radiology, Nuclear Medicine and Imaging, 17 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Yariv Mazor's work include Monoclonal and Polyclonal Antibodies Research (19 papers), Glycosylation and Glycoproteins Research (10 papers) and Bacteriophages and microbial interactions (5 papers). Yariv Mazor is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (19 papers), Glycosylation and Glycoproteins Research (10 papers) and Bacteriophages and microbial interactions (5 papers). Yariv Mazor collaborates with scholars based in United States, Israel and Germany. Yariv Mazor's co-authors include Ehud Gazit, Itai Benhar, George Georgiou, Yair Porat, Shimon Efrat, Thomas Van Blarcom, Sharon Gilead, William F. Dall’Acqua, Herren Wu and Chunning Yang and has published in prestigious journals such as Nature Biotechnology, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

Yariv Mazor

24 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yariv Mazor United States 16 860 669 261 236 215 24 1.3k
Makoto Nakakido Japan 19 876 1.0× 262 0.4× 56 0.2× 126 0.5× 118 0.5× 81 1.2k
Tilman Schlothauer Germany 23 1.6k 1.9× 1.3k 2.0× 67 0.3× 570 2.4× 242 1.1× 45 2.2k
Simon E. Hufton Netherlands 20 1.4k 1.6× 1.3k 1.9× 63 0.2× 448 1.9× 286 1.3× 32 2.0k
Thomas L. Ciardelli United States 23 604 0.7× 333 0.5× 85 0.3× 556 2.4× 190 0.9× 52 1.3k
Dorothea Reilly United States 20 1.2k 1.4× 588 0.9× 34 0.1× 292 1.2× 415 1.9× 28 1.7k
Ewa Pol Sweden 13 634 0.7× 203 0.3× 79 0.3× 179 0.8× 366 1.7× 17 1.1k
Lionel Rougé France 15 699 0.8× 188 0.3× 117 0.4× 264 1.1× 338 1.6× 33 1.2k
Noritaka Hashii Japan 22 1.2k 1.3× 317 0.5× 59 0.2× 354 1.5× 93 0.4× 69 1.4k
Kenneth W. Walker United States 16 865 1.0× 151 0.2× 165 0.6× 191 0.8× 428 2.0× 25 1.4k
Gabriele Matschiner Germany 14 517 0.6× 200 0.3× 89 0.3× 383 1.6× 123 0.6× 25 950

Countries citing papers authored by Yariv Mazor

Since Specialization
Citations

This map shows the geographic impact of Yariv Mazor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yariv Mazor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yariv Mazor more than expected).

Fields of papers citing papers by Yariv Mazor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yariv Mazor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yariv Mazor. The network helps show where Yariv Mazor may publish in the future.

Co-authorship network of co-authors of Yariv Mazor

This figure shows the co-authorship network connecting the top 25 collaborators of Yariv Mazor. A scholar is included among the top collaborators of Yariv Mazor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yariv Mazor. Yariv Mazor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Comer, Frank I., Yariv Mazor, Elaine M. Hurt, et al.. (2023). Abstract 5736: AZD9592: An EGFR-cMET bispecific antibody-drug conjugate (ADC) targeting key oncogenic drivers in non-small-cell lung cancer (NSCLC) and beyond. Cancer Research. 83(7_Supplement). 5736–5736. 16 indexed citations
3.
Malhotra, Deepali, Eleanor Clancy‐Thompson, Bilal Omar, et al.. (2022). 469 Preclinical studies support clinical development of AZD2936, a monovalent bispecific humanized antibody targeting PD-1 and TIGIT. Regular and Young Investigator Award Abstracts. A489–A489. 5 indexed citations
4.
Mazor, Yariv, et al.. (2021). A single homogeneous assay for simultaneous measurement of bispecific antibody target binding. Journal of Immunological Methods. 496. 113099–113099. 2 indexed citations
5.
Wang, Bo, Chunning Yang, Xiaofang Jin, et al.. (2019). Regulation of antibody-mediated complement-dependent cytotoxicity by modulating the intrinsic affinity and binding valency of IgG for target antigen. mAbs. 12(1). 1690959–1690959. 39 indexed citations
6.
Mazor, Yariv, Kris F. Sachsenmeier, Chunning Yang, et al.. (2017). Enhanced tumor-targeting selectivity by modulating bispecific antibody binding affinity and format valence. Scientific Reports. 7(1). 40098–40098. 89 indexed citations
7.
Mazor, Yariv, Chunning Yang, M. Jack Borrok, et al.. (2016). Enhancement of Immune Effector Functions by Modulating IgG’s Intrinsic Affinity for Target Antigen. PLoS ONE. 11(6). e0157788–e0157788. 35 indexed citations
8.
Mazor, Yariv, Vaheh Oganesyan, Chunning Yang, et al.. (2015). Improving target cell specificity using a novel monovalent bispecific IgG design. mAbs. 7(2). 377–389. 108 indexed citations
9.
Mazor, Yariv, Anna M. Hansen, Chunning Yang, et al.. (2015). Insights into the molecular basis of a bispecific antibody's target selectivity. mAbs. 7(3). 461–469. 61 indexed citations
10.
Xiao, Xiaodong, Yan Chen, Changshou Gao, et al.. (2015). A Novel Dual Expression Platform for High Throughput Functional Screening of Phage Libraries in Product like Format. PLoS ONE. 10(10). e0140691–e0140691. 11 indexed citations
11.
Oganesyan, Vaheh, Yariv Mazor, Chunning Yang, et al.. (2015). Structural insights into the interaction of human IgG1 with FcγRI: no direct role of glycans in binding. Acta Crystallographica Section D Biological Crystallography. 71(11). 2354–2361. 18 indexed citations
12.
Mazor, Yariv, Thomas Van Blarcom, Sean M. Carroll, & George Georgiou. (2010). Selection of full‐length IgGs by tandem display on filamentous phage particles and Escherichia coli fluorescence‐activated cell sorting screening. FEBS Journal. 277(10). 2291–2303. 33 indexed citations
13.
Ge, Xin, Yariv Mazor, Scott Hunicke‐Smith, Andrew D. Ellington, & George Georgiou. (2010). Rapid construction and characterization of synthetic antibody libraries without DNA amplification. Biotechnology and Bioengineering. 106(3). 347–357. 27 indexed citations
14.
Mazor, Yariv, Thomas Van Blarcom, Brent L. Iverson, & George Georgiou. (2008). E-clonal antibodies: selection of full-length IgG antibodies using bacterial periplasmic display. Nature Protocols. 3(11). 1766–1777. 39 indexed citations
15.
Mazor, Yariv, Thomas Van Blarcom, Brent L. Iverson, & George Georgiou. (2008). Isolation of Full-Length IgG Antibodies from Combinatorial Libraries Expressed in Escherichia coli. Methods in molecular biology. 525. 217–239. 8 indexed citations
16.
Mazor, Yariv, Roy Noy, Winfried S. Wels, & Itai Benhar. (2007). chFRP5-ZZ-PE38, a large IgG-toxin immunoconjugate outperforms the corresponding smaller FRP5(Fv)-ETA immunotoxin in eradicating ErbB2-expressing tumor xenografts. Cancer Letters. 257(1). 124–135. 19 indexed citations
17.
Mazor, Yariv, Itay Barnea, Iafa Keydar, & Itai Benhar. (2007). Antibody internalization studied using a novel IgG binding toxin fusion. Journal of Immunological Methods. 321(1-2). 41–59. 54 indexed citations
18.
Mazor, Yariv, Iafa Keydar, & Itai Benhar. (2004). Humanization and epitope mapping of the H23 anti-MUC1 monoclonal antibody reveals a dual epitope specificity. Molecular Immunology. 42(1). 55–69. 12 indexed citations
19.
Mazor, Yariv, Sharon Gilead, Itai Benhar, & Ehud Gazit. (2002). Identification and Characterization of a Novel Molecular-recognition and Self-assembly Domain within the Islet Amyloid Polypeptide. Journal of Molecular Biology. 322(5). 1013–1024. 170 indexed citations
20.
Bach, Horacio, et al.. (2001). Escherichia coli maltose-binding protein as a molecular chaperone for recombinant intracellular cytoplasmic single-chain antibodies 1 1Edited by R. Huber. Journal of Molecular Biology. 312(1). 79–93. 153 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Makoto Nakakido Breakdown of academic impact, for papers by Tilman Schlothauer Breakdown of academic impact, for papers by Simon E. Hufton Breakdown of academic impact, for papers by Thomas L. Ciardelli Breakdown of academic impact, for papers by Dorothea Reilly Breakdown of academic impact, for papers by Ewa Pol Breakdown of academic impact, for papers by Lionel Rougé Breakdown of academic impact, for papers by Noritaka Hashii Breakdown of academic impact, for papers by Kenneth W. Walker Breakdown of academic impact, for papers by Gabriele Matschiner
Rankless by CCL
2026